NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 22.87% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 22.3% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.16% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.61% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.58% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.54% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.32% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.2% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.09% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.94% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.79% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.03% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.85% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.49% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 1.39% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 1.19% |
| ARVN | Arvinas Inc | Healthcare | Biotechnology | 0.94% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 0.88% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.7% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.